ELOCTATE

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: 44f7e0b12863a550
Drug Approval Canada Name: ELOCTATE
Product Name: ELOCTATE
Status: Marketed
Status Date: 2021-11-10
Original Market Date: 2016-01-15
Din: 02430339
Drug Class: Human
Dosage Form: Kit , Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 20:28.16
Atc Original: B02BD02 COAGULATION FACTOR VIII
Atc Name: b 02 bd 02
Aig Number: 0155970005
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

ANTIHEMOPHILIC FACTOR (RECOMBINANT BDD), FC FUSION PROTEIN

1500 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

44f7e0b12863a550

Type

Standard